Literature DB >> 17570941

Role of transcription factors in podocytes.

Anne Rascle1, Hani Suleiman, Tanja Neumann, Ralph Witzgall.   

Abstract

Despite a wealth of information on structural proteins, comparatively little is known on the transcriptional regulation of podocyte structure and function. In this review we will highlight those transcription factors which, by gene inactivation or classical transgenic experiments, have been shown to be essential for podocytes or probably will turn out to be so. The tumor suppressor protein WT1 is not only indispensable for the initial stages of kidney development, but also very likely maintains the integrity of the fully differentiated podocyte. In the kidney, the LIM homeodomain transcription factor LMX1B is specifically synthesized in podocytes, and mutations in LMX1B lead to nail-patella syndrome and the associated nephropathy. Other transcription factors such as hypoxia-inducible factors and PAX2 are likely to play a role in podocytes, whereas the significance of others, e.g. of POD1 and CITED2, is more speculative at this point. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570941     DOI: 10.1159/000101794

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  9 in total

1.  Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus.

Authors:  Jeffrey T White; Bo Zhang; Débora M Cerqueira; Uyen Tran; Oliver Wessely
Journal:  Development       Date:  2010-04-28       Impact factor: 6.868

2.  LMX1B is essential for the maintenance of differentiated podocytes in adult kidneys.

Authors:  Tillmann Burghardt; Jürgen Kastner; Hani Suleiman; Eric Rivera-Milla; Natalya Stepanova; Claudio Lottaz; Marion Kubitza; Carsten A Böger; Sarah Schmidt; Mathias Gorski; Uwe de Vries; Helga Schmidt; Irmgard Hertting; Jeffrey Kopp; Anne Rascle; Markus Moser; Iris M Heid; Richard Warth; Rainer Spang; Joachim Wegener; Claudia T Mierke; Christoph Englert; Ralph Witzgall
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

Review 3.  Xenopus pronephros development--past, present, and future.

Authors:  Oliver Wessely; Uyen Tran
Journal:  Pediatr Nephrol       Date:  2011-04-17       Impact factor: 3.714

4.  Amino acid transporter LAT3 is required for podocyte development and function.

Authors:  Yuji Sekine; Yukino Nishibori; Yoshihiro Akimoto; Akihiko Kudo; Noriko Ito; Daisuke Fukuhara; Ryota Kurayama; Eiji Higashihara; Ellappan Babu; Yoshikatsu Kanai; Katsuhiko Asanuma; Michio Nagata; Arindam Majumdar; Karl Tryggvason; Kunimasa Yan
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

5.  Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset.

Authors:  Maja T Lindenmeyer; Felix Eichinger; Kontheari Sen; Hans-Joachim Anders; Ilka Edenhofer; Deborah Mattinzoli; Matthias Kretzler; Maria P Rastaldi; Clemens D Cohen
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

6.  Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function.

Authors:  Bing Guo; Qing Lyu; Orazio J Slivano; Ronald Dirkx; Christine K Christie; Jan Czyzyk; Aram F Hezel; Ali G Gharavi; Eric M Small; Joseph M Miano
Journal:  J Am Soc Nephrol       Date:  2017-11-07       Impact factor: 10.121

7.  Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy.

Authors:  Laura Barisoni; H William Schnaper; Jeffrey B Kopp
Journal:  Arch Pathol Lab Med       Date:  2009-02       Impact factor: 5.534

8.  A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.

Authors:  Chun-Liang Lin; Yung-Chien Hsu; Yu-Ting Huang; Ya-Hsueh Shih; Ching-Jen Wang; Wen-Chih Chiang; Pey-Jium Chang
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 12.137

9.  How are podocytes affected in nail-patella syndrome?

Authors:  Ralph Witzgall
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.